Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Sabra Health Care REIT, Inc. ( SBRA - Snapshot Report ) recently announced that it has entered into an agreement to acquire four skilled nursing facilities for $97.5 million in the Mid-Atlantic Region. The facilities will be functional under a long-term lease and are expected to provide a yield of 8.75% on cash rent. The transaction is expected to be completed by the third quarter of 2011.
Additionally, Sabra Health Care acquired a 70-bed hospital named Texas Regional Medical Center and a 120-bed skilled nursing facility named Oak Brook Health Care Center in Texas.
This acquisition is a strategic move on the company’s part to expand and diversify its portfolio in the Mid-Atlantic region. The company primarily intends to expand its portfolio through the acquisition of skilled nursing and long-term care facilities. The company’s strategy of diversifying its portfolio is backed by an excellent management team.
Sabra Health Care is a self-administered real estate investment trust (REIT) and through its subsidiaries owns and invests in real estate serving the healthcare industry. It invests in assets that provide the best opportunity to create long-term shareholder value. As of March 31, 2011, Sabra Health Care had properties located in 19 states including 9,603 licensed beds.
Sabra Health Care currently retains a Zacks #4 Rank, which translates into a short-term Underperform rating. We are also maintaining our long-term Neutral recommendation on the stock. One of its competitors, Health Care REIT Inc. ( HCN - Analyst Report ) currently retains a Zacks #3 Rank, which translates into a short term Hold rating.
Read the full reports :
Analyst Report on HCN
Snapshot Report on SBRA